Document is current
Any future updates will be listed below
-
Authors
Kilpatrick, Lisa A.
Church, Arpana
Meriwether, David
Mahurkar-Joshi, Swapna
Li, Vince W.
Sohn, Jessica
Reist, Juliana
Labus, Jennifer S.
Dong, Tien
Jacobs, Jonathan P.
Naliboff, Bruce D.
Chang, Lin
Mayer, Emeran A.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U54DK123755)
- License Information
-
More Information
Article History
Received: 7 August 2024
Accepted: 4 April 2025
First Online: 18 April 2025
Declarations
:
: This study was approved by the Institutional Review Board at the University of California, Los Angeles’s Office of Protection for Research Subjects (Nos. 20–000540 and 20–000515). All participants provided written informed consent.
: Not applicable.
: A.C. is a research consultant for YAMAHA. E.A.M. is a member of the scientific advisory boards of Danone, Axial Therapeutics, Amare, Mahana Therapeutics, Pendulum, Bloom Biosciences, and APC Microbiome Ireland. L.C. serves as an advisory board member or consultant for Ardelyx, Arena Pharmaceuticals, Bausch Health, Immunic, Ironwood Pharmaceuticals, Inc., Mauna Kea Technologies, and Trellus; and receives grant support from AnX Robotica, Arena Pharmaceuticals, and Ironwood Pharmaceuticals. All other authors declare no conflict of interest.
